Toggle light / dark theme

Scientists have discovered a new species of crab that swam the seas 95 million years ago — and behold, it could be the next Pixar character.

The small, pocket-size crab, named Callichimaera perplexa, was different than its modern cousins.

This crab sported a tiny lobster-esque shell, with legs flattened like oars, and huge Pound Puppies-style peepers that protruded from its head — a trait that indicates the creature used its eyes actively for whatever it did, researchers said.

Read more

China’s Gen Z isn’t impressed by glitzy brand names and traditional advertising campaigns. Many are looking beyond the physical stores and e-commerce portals their predecessors preferred. They’re buying goods suggested by social media influencers known as wanghong. And they’re using messaging, short videos, livestreaming, and social media apps as gateways to making those purchases.


Traditional retail and e-commerce hold little interest for consumers who are wedded to smartphones and take their cues from influencers.

Read more

This is a Chinese supercar concept. It is called the ME Sports (ME-S for short), and arrives from a new company called Enovate. When it finally sees the light of production in the year 2021, it plans on going really, really fast.

Like, 0-62mph in around three seconds, fast. And doesn’t it look sweet?

Speaking to TopGear.com at this year’s Shanghai motor show, an Enovate spokesperson said that because the company is shiny and new, it wanted to make something ‘iconic’.

Read more

Burdening occurrence of dengue fever across the Asia-Pacific region has prompted the demand for effective vaccines and medications to supress this viral malaise. While several pharmaceutical companies are striving to develop a cure for dengue, the fever’s incidence rate in Asia-Pacific is rising at an alarming rate. A recent report published by Future Market Insights predicts that in 2017, an estimated 70.3% of global dengue vaccines market will be dominated by Asia-Pacific. Through 2027, the region will continue to be the largest market for dengue vaccines, procuring a majority revenue share and projecting revenue growth at a 17.4% CAGR.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1763

Future Market Insights also observes Latin America as the second-largest market for dengue vaccines, and is expected to rake in US$ 288.7 Mn towards the end of 2027. The report, titled “Dengue Vaccines Market: Global Industry Analysis and Opportunity Assessment, 2017–2027,” expects that more and more pharmaceutical giants from across the globe will be partaking in the market’s growth in the years to come. Currently, the market is witnessing active participation of French drugmaker, Sanofi S.A., while vaccines being formulated by companies such as Biological E. Limited, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Merck & Co. Inc., Vabiotech, Butantan Institute, and Panacea Biotech Ltd. are under multiple phases of development.

Read more